|
Mechanismσ1 receptor modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismGluN2B antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismN-type calcium channel inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Traxion Therapeutics, Inc.
0 Patents (Medical) associated with Traxion Therapeutics, Inc.
100 Deals associated with Traxion Therapeutics, Inc.
100 Translational Medicine associated with Traxion Therapeutics, Inc.